Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01970332 · ClinicalTrials.gov registry record · NA

Mechanisms That Produce the Leg Dysfunction of Claudication & Treatment Strategies

A NA study of Peripheral Arterial Disease, sponsored by University of Nebraska.

Completed
Registry status
NA
Development phase
220
Enrollment target
1
Study location

NCT01970332 is a NA study of Peripheral Arterial Disease that has completed, run by University of Nebraska. The registered enrollment target is 220 participants, below the 4,203-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01970332, a NA study of Peripheral Arterial Disease, has completed, sponsored by University of Nebraska.

COMPLETED
Registry status
NA
Development phase
220 participants
Enrollment target
1
Study location

Study Summary

Intermittent claudication afflicts 5% of the US population older than 55 years of age and develops along with hardening of the arteries of the legs. Claudicating patients limp and can only walk very short distances because their legs hurt. This protocol evaluates the mechanisms that may produce the leg dysfunction of claudication and its successful completion can ultimately produce significant new diagnostic and treatment strategies for the care of claudicating patients.

Conditions Studied

Peripheral Arterial Disease

Interventions

  • PROCEDURE Revascularization Surgery
  • OTHER Supervised exercise therapy

Study Locations (1)

Nebraska

  • Veterans Affairs Medical Center, Omaha - Omaha

Trial Details

FieldValue
Enrollment Target 220 participants
Start Date 2010-09-01
Est. Completion 2016-05-30
Phase NA

Sponsor

University of Nebraska

407 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01970332

The ClinicalTrials.gov registry entry for NCT01970332 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 220 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,203-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (95% lower). The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Peripheral Arterial Disease appearing as the primary indexed condition, and to 2 interventions - of which Revascularization Surgery is the first listed.

NCT01970332 reports 1 study location spanning 1 distinct geographic area - top geographies include Nebraska.

Frequently Asked Questions

What is clinical trial NCT01970332 about?

NCT01970332 is a clinical study titled "Mechanisms That Produce the Leg Dysfunction of Claudication & Treatment Strategies". Intermittent claudication afflicts 5% of the US population older than 55 years of age and develops along with hardening of the arteries of the legs. Claudicating patients limp and can only walk very short distances because their legs hurt. This protocol evaluates the mechanisms that may produce the ...

What is the current status of trial NCT01970332?

This trial is currently completed. It is a NA study. The enrollment target is 220 participants. The study started on 2010-09-01. Estimated completion is 2016-05-30.

What conditions does trial NCT01970332 study?

This clinical trial studies the following conditions: Peripheral Arterial Disease.

What interventions are being tested in trial NCT01970332?

The interventions under investigation include: Revascularization Surgery (PROCEDURE), Supervised exercise therapy (OTHER).

Who is sponsoring clinical trial NCT01970332?

This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01970332 being conducted?

This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Peripheral Arterial Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Peripheral Arterial Disease

All registered trials for this condition

Nebraska

All trials with a study site in Nebraska

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.